158 related articles for article (PubMed ID: 37651201)
21. Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.
Beal BT; Chu MB; Siegfried EC
Pediatr Dermatol; 2014; 31(6):754-6. PubMed ID: 25424217
[TBL] [Abstract][Full Text] [Related]
22. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
He L; Huang G
J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
[TBL] [Abstract][Full Text] [Related]
23. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
24. Episcleral infantile hemangioma successfully treated with topical timolol.
Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R
Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087
[TBL] [Abstract][Full Text] [Related]
25. Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck?
Bly RA; Perkins J; Parikh SR
Laryngoscope; 2017 Jan; 127(1):4-5. PubMed ID: 27808405
[No Abstract] [Full Text] [Related]
26. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
Chan H; McKay C; Adams S; Wargon O
Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
[TBL] [Abstract][Full Text] [Related]
27. Scalp Infantile Hemangioma Complicated by Life-Threatening Bleeding.
Charny JW; Moon AT; Treat JR
Pediatr Dermatol; 2017 Jul; 34(4):473-475. PubMed ID: 28488296
[TBL] [Abstract][Full Text] [Related]
28. Predictors of treatment responses of superficial infantile hemangiomas to topical timolol.
Zheng H; Cai Y; Xu Y; Yu Q; Kang B; Chen C; Gong X; Li W
Dermatol Ther; 2022 Nov; 35(11):e15833. PubMed ID: 36106484
[TBL] [Abstract][Full Text] [Related]
29. Medical Management of Infantile Hemangiomas: An Update.
Colmant C; Powell J
Paediatr Drugs; 2022 Jan; 24(1):29-43. PubMed ID: 34677814
[TBL] [Abstract][Full Text] [Related]
30. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
Chakhunashvili K; Kvirkvelia E; Todua N; Chakhunashvili DG
BMC Pediatr; 2024 Feb; 24(1):138. PubMed ID: 38395819
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
32. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
Tawfik AA; Alsharnoubi J
Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
[TBL] [Abstract][Full Text] [Related]
33. Infantile hemangiomas with conjunctival involvement: An underreported occurrence.
Theiler M; Baselga E; Gerth-Kahlert C; Mathes EF; Schwieger-Briel A; Chaloupka K; Weibel L; Frieden IJ
Pediatr Dermatol; 2017 Nov; 34(6):681-685. PubMed ID: 29144051
[TBL] [Abstract][Full Text] [Related]
34. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.
Semkova K; Kazandjieva J
Clin Exp Dermatol; 2013 Mar; 38(2):143-6. PubMed ID: 22731954
[TBL] [Abstract][Full Text] [Related]
35. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
36. Topical ophthalmic solution in infantile hemangioma.
Jha AK; Mallik SK; Raihan M
J Postgrad Med; 2012; 58(2):163-5. PubMed ID: 22718070
[No Abstract] [Full Text] [Related]
37. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
38. Using Topical Citric Acid to Treat an Infected Ulcerated Hemangioma in an Infant: A Case Study.
Nagoba B; Davane M; Warad B; Jamadar N; Gavkare AM
Wounds; 2021 Feb; 33(2):E17-E19. PubMed ID: 33914691
[TBL] [Abstract][Full Text] [Related]
39. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Huang H; Chen X; Cai B; Yu J; Wang B
Dermatol Ther; 2022 Dec; 35(12):e15907. PubMed ID: 36205218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
